1.
Efficacy of transcutaneous retrobulbar amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: A single-center retrospective observational study. SJHR-Africa [Internet]. 2025 Dec. 30 [cited 2026 Aug. 11];6(12):8. Available from: https://sjhrafrica.org.sjhresearchafrica.org/index.php/public-html/article/view/2192